Published November 1, 2007 | Version v1
Journal article

Skin: Major target organ of allergic reactions to small molecular weight compounds

  • 1. Department of Dermatology and Allergology, Univ.-Hospital, RWTH Aachen, Pauwelsstr. 30, D-52074 Aachen (Germany)
  • 2. Dermatochemistry and Skin Allergy, Department of Chemistry, Goeteborg University, SE-412 96 Goeteborg (Sweden)

Description

Skin is a major target organ for allergic reactions to small molecular weight compounds. Drug allergic reactions may be life-threatening such as in the case of anaphylactic reactions or bullous drug reactions and occur in about 5% of all hospitalized patients. Allergic contact dermatitis has an enormous influence on the social life of the patient because it is the most frequent reason for occupational skin diseases and the treatment and prevention of this disease cost approximately Euro 3 billion per year in Germany. The different proposed pathophysiological pathways leading to a drug eruption are discussed in this paper. All major enzymes which are involved in the metabolism of xenobiotica were shown to be present in skin. Evidence supporting the role of metabolism in the development of drug allergy and allergic contact dermatitis is demonstrated in the example of sulphonamides and fragrances

Availability note (English)

Available from http://dx.doi.org/10.1016/j.taap.2007.01.004

Additional details

Identifiers

DOI
10.1016/j.taap.2007.01.004;
PII
S0041-008X(07)00020-8;

Publishing Information

Journal Title
Toxicology and Applied Pharmacology
Journal Volume
224
Journal Issue
3
Journal Page Range
p. 313-317
ISSN
0041-008X
CODEN
TXAPA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
39090261
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
ALLERGY; COST; DERMATITIS; DRUGS; ENZYMES; METABOLISM; MOLECULAR WEIGHT; PATIENTS; SKIN
Descriptors DEC
BODY; DISEASES; ORGANIC COMPOUNDS; ORGANS; PATHOLOGICAL CHANGES; PROTEINS; SKIN DISEASES

Optional Information

Copyright
Copyright (c) 2007 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.